Related by context. Frequent words. (Click for all words.) 59 soft tissue sarcoma 58 R sorafenib tablets 56 Amrubicin 56 EGFR expressing metastatic colorectal 54 hormone refractory prostate cancer 54 refractory PTCL 54 refractory Hodgkin lymphoma 54 plus prednisone 54 MOZOBIL 54 Phase IIb clinical 53 Genasense R 53 metastatic colorectal cancer 53 Phase 2b clinical 53 glufosfamide 53 OncoVEX GM CSF 53 relapsed refractory multiple myeloma 53 cangrelor 53 alvimopan 53 unresectable 53 refractory multiple myeloma 53 Zelrix 53 mRCC 53 dacarbazine 53 pralatrexate 52 non squamous 52 HGS ETR1 52 metastatic hormone refractory 52 Cloretazine R VNP#M 52 FavId 52 plus gemcitabine 52 Omigard 52 Nexavar ® 52 lymphoma CTCL 52 COPEGUS 52 phase IIb 52 luteinizing hormone releasing 52 B CLL 51 Zerenex 51 OPAXIO 51 relapsed multiple myeloma 51 vernakalant oral 51 aflibercept 51 FOLOTYN 51 adecatumumab 51 TELCYTA 51 vernakalant iv 51 Copegus 51 registrational 51 anticancer compound 51 confirmatory Phase III 51 TOCOSOL Paclitaxel 51 apaziquone 51 talactoferrin 51 ridaforolimus 51 mCRC 51 ApoB SNALP 51 Biologics License Application BLA 51 Empatic 51 Azedra 50 SILENOR TM 50 Virulizin R 50 L MTP PE 50 bazedoxifene 50 olmesartan medoxomil 50 custirsen 50 registrational trial 50 www.allos.com 50 Act PDUFA date 50 picoplatin 50 plus dexamethasone 50 Phase 1b clinical 50 methylnaltrexone 50 refractory peripheral T 50 advanced carcinoid 50 tesetaxel 50 CCX# 49 Phase 2a clinical 49 deforolimus 49 goserelin 49 Pirfenidone 49 sodium Injection 49 HER2 positive metastatic breast 49 pivotal Phase III 49 ZEVALIN 49 BLA submission 49 tesmilifene 49 ofatumumab 49 BrachySil 49 IIa clinical trial 49 Investigational Device Exemption 49 palifosfamide 49 Phase Ib 49 drug conjugate 49 BiTE antibody 49 Acute Myeloid Leukemia AML 49 Rebif R 49 pseudobulbar affect PBA 49 NEBIDO 49 pertuzumab 49 www.incyte.com 49 Azixa